Investors.legendbiotech.com

Legend Biotech Announces Acceptance of Its New Drug …

WebIn February 2022, cilta-cel was approved by the U.S. Food and Drug Administration (FDA) under the brand name CARVYKTI ® for the treatment of adults with …

Actived: 1 days ago

URL: https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-announces-acceptance-its-new-drug-application

Patient-Reported Outcomes from the CARTITUDE-4 Study Showed …

WebCARVYKTI ® Important Safety Information. CARVYKTI ® INDICATIONS AND USAGE. CARVYKTI ® (ciltacabtagene autoleucel) is a B-cell maturation antigen …

Category:  Health Go Health

Press Release Details

WebAbout CARTITUDE-1. CARTITUDE-1 (NCT03548207) is a Phase 1b/2, open-label, multicenter study evaluating the safety and efficacy of cilta-cel in adults with …

Category:  Health Go Health

Press Release Details

WebIn January 2023, Legend announced that the CARTITUDE-4 study met its primary endpoint of showing a statistically significant improvement in progression-free …

Category:  Health Go Health

Legend Biotech Announces Positive CHMP Opinion for CARVYKTI

WebCARVYKTI ® is the first CAR-T therapy for patients with relapsed and refractory multiple myeloma to receive a positive CHMP opinion for second line …

Category:  Health Go Health

Legend Biotech to Showcase Leadership in Multiple Myeloma …

WebAbstract Number. Title. Information. Abstract #1021 Oral Presentation The Phase 2 CARTITUDE-2 Trial: Updated Efficacy and Safety of Ciltacabtagene Autoleucel …

Category:  Health Go Health

Press Release Details

WebAbout Cilta-cel Cilta-cel is an investigational chimeric antigen receptor T cell (CAR-T) therapy, formerly identified as JNJ-4528 in the U.S. and Europe and LCAR …

Category:  Health Go Health

Press Release Details

WebSOMERSET, N.J.--(BUSINESS WIRE)--Jan. 27, 2023-- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company …

Category:  Health Go Health

Legend Biotech Reports Fourth Quarter and Full Year 2023 …

WebSOMERSET, N.J.--(BUSINESS WIRE)--Mar. 11, 2024-- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today …

Category:  Health Go Health

Press Release Details

WebAbout Multiple Myeloma. Multiple myeloma is an incurable blood cancer that starts in the bone marrow and is characterized by an excessive proliferation of plasma …

Category:  Cancer Go Health

Legend Biotech and Noile-Immune Biotech Announce …

WebCollaboration focuses on advancing the next generation of T-cell products for the treatment of solid tumors. SOMERSET, N.J., USA and TOKYO, Japan- …

Category:  Health Go Health

Legend Biotech Corporation

WebL e ge n d B i ote c h A n n ou n c e me n t R e gar d i n g A S H 2020 D ata P re s e n tati on for C i l ta-c e l On November 5, 2020, Legend Biotech Corporation …

Category:  Health Go Health

March 11, 2024 Fourth Quarter and Full Year 2023

WebStatements in this presentation about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, …

Category:  Health Go Health

Press Release Details

WebAdditional data at this year’s meetings will include longer-term results from the final protocol-specified analysis of the CARTITUDE-1 study (NCT03548207), which …

Category:  Health Go Health

Legend Biotech Announces FDA Clearance of the IND for LB1901, …

WebSOMERSET, N.J.--(BUSINESS WIRE)--Dec. 14, 2020-- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage …

Category:  Health Go Health

th Annual J.P. Morgan Healthcare Conference

WebFUTURE PIPELINE Global collaboration with Janssen for the development of cilta-cel established December 2017 Received an upfront payment of $350 million and a …

Category:  Health Go Health

Legend Biotech Announces Advancement of Global Manufacturing

WebSOMERSET, N.J. -- (BUSINESS WIRE)--Jun. 22, 2021-- Legend Biotech Corporation ( Legend Biotech, NASDAQ: LEGN), a global clinical-stage …

Category:  Health Go Health

Legend Biotech Corporation Announces Pricing of Public Offering

WebSOMERSET, N.J.--(BUSINESS WIRE)--Dec. 16, 2021-- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage …

Category:  Health Go Health

Legend Biotech to Participate in the 40th Annual J.P. Morgan …

WebSOMERSET, N.J.--(BUSINESS WIRE)--Jan. 4, 2022-- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global, clinical-stage biotechnology …

Category:  Health Go Health

Legend Biotech Corporation Announces Confidential …

WebLegend Biotech Corporation Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering Somerset, NJ (March 9, 2020):-- Legend …

Category:  Health Go Health

November 20, 2023 Third Quarter 2023 Financial Results

WebStatements in this presentation about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, …

Category:  Health Go Health